284 related articles for article (PubMed ID: 38543629)
1. Yeast-Based Screening of Anti-Viral Molecules.
Srivastava V; Kumar R; Ahmad A
Microorganisms; 2024 Mar; 12(3):. PubMed ID: 38543629
[TBL] [Abstract][Full Text] [Related]
2. Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.
Nakata M; Tang W
Drug Discov Ther; 2008 Oct; 2(5):262-3. PubMed ID: 22504718
[TBL] [Abstract][Full Text] [Related]
3. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
6. Development of anti-viral agents using molecular modeling and virtual screening techniques.
Kirchmair J; Distinto S; Liedl KR; Markt P; Rollinger JM; Schuster D; Spitzer GM; Wolber G
Infect Disord Drug Targets; 2011 Feb; 11(1):64-93. PubMed ID: 21303343
[TBL] [Abstract][Full Text] [Related]
7. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
8. Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery.
Jia H; Hu L; Zhang J; Huang X; Jiang Y; Dong G; Liu C; Liu X; Kim M; Zhan P
RSC Med Chem; 2024 Jan; 15(1):70-80. PubMed ID: 38283223
[TBL] [Abstract][Full Text] [Related]
9. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles.
Choi W; Kim YH; Min J
Microbiol Spectr; 2023 Feb; 11(1):e0266122. PubMed ID: 36688634
[TBL] [Abstract][Full Text] [Related]
11. Yeast for virus research.
Zhao RY
Microb Cell; 2017 Sep; 4(10):311-330. PubMed ID: 29082230
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors.
Chang KO; Kim Y; Lovell S; Rathnayake AD; Groutas WC
Viruses; 2019 Feb; 11(2):. PubMed ID: 30823509
[TBL] [Abstract][Full Text] [Related]
13. Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.
Kido H; Okumura Y; Takahashi E; Pan HY; Wang S; Chida J; Le TQ; Yano M
J Mol Genet Med; 2008 Nov; 3(1):167-75. PubMed ID: 19565019
[TBL] [Abstract][Full Text] [Related]
14. Yeast-based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase.
Sun Y; Wang Z; Tao J; Wang Y; Wu A; Yang Z; Wang K; Shi L; Chen Y; Guo D
Antiviral Res; 2014 Apr; 104():156-64. PubMed ID: 24530452
[TBL] [Abstract][Full Text] [Related]
15. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract][Full Text] [Related]
16. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752
[TBL] [Abstract][Full Text] [Related]
17. Recent Development in Small Molecules for SARS-CoV-2 and the Opportunity for Fragment-Based Drug Discovery.
Mahato S
Med Chem; 2022; 18(8):847-858. PubMed ID: 35156586
[TBL] [Abstract][Full Text] [Related]
18. Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents.
Gabbianelli R; Shahar E; de Simone G; Rucci C; Bordoni L; Feliziani G; Zhao F; Ferrati M; Maggi F; Spinozzi E; Mahajna J
Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004113
[TBL] [Abstract][Full Text] [Related]
19. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.
Gasparini R; Amicizia D; Lai PL; Bragazzi NL; Panatto D
J Prev Med Hyg; 2014 Dec; 55(4):109-29. PubMed ID: 26137785
[TBL] [Abstract][Full Text] [Related]
20. Potent Protease Inhibitors of Highly Pathogenic Lagoviruses: Rabbit Hemorrhagic Disease Virus and European Brown Hare Syndrome Virus.
Perera KD; Johnson D; Lovell S; Groutas WC; Chang KO; Kim Y
Microbiol Spectr; 2022 Aug; 10(4):e0014222. PubMed ID: 35766511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
